Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

Medscape Women’s Health Joins Supporters in Sponsorship of SWHR’s 2025 Gala

Medscape Women’s Health is proud to announce its sponsorship of the Society for Women's Health Research (SWHR) 2025 Gala, which took place on Wednesday, April 30, 2025, celebrating 35 Years...

Medscape Education

- PMLiVE

Novartis to expand renal disease pipeline with $1.7bn Regulus acquisition

The agreement includes a candidate for autosomal dominant polycystic kidney disease

- PMLiVE

FDA approves Abeona’s epidermolysis bullosa gene therapy Zevaskyn

The sheet-based treatment is expected to be available from the third quarter of this year

- PMLiVE

UK government’s AMR study highlights importance of appropriate antibiotic use

The UKHSA found that some bacteria are already becoming resistant to ceftazidime/avibactam

- PMLiVE

IPG Health announces evolution of medical communications offering

The network has introduced a new agency and aligned its medical communications, medical affairs and publications capabilities

- PMLiVE

Medical remote monitoring: a revolution driven by connected patches

Connected patches can be used to monitor vital patient parameters in real time, including heart rate, oxygen saturation, blood glucose or respiration

- PMLiVE

AXON NAMES NEW PRESIDENT AND MANAGING PARTNER, TINA HAHN, AS RALPH SUTTON CHANGES LANE

April 30, 2025—Tina Hahn, who joined AXON in 2012 as Vice President, will now take on the role of AXON’s President and Managing Partner.

AXON

- PMLiVE

Eli Lilly and Creyon Bio enter oligonucleotide therapy partnership worth over $1bn

The companies will aim to develop RNA-targeted drugs for a broad range of diseases

- PMLiVE

AbbVie’s JAK inhibitor Rinvoq granted FDA approval to treat giant cell arteritis

The drug could allow patients to taper off steroids and achieve sustained remission

- PMLiVE

AstraZeneca’s Calquence regimens recommended by CHMP for chronic lymphocytic leukaemia

It is hoped that the fixed-duration treatments will reduce the risk of adverse events and drug resistance

- PMLiVE

Mastering pharma capability development cogs

The blueprint for success

- PMLiVE

Data visualization: translating complex data into emotive storytelling

By Ben Dean

Amiculum

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links